Alka-Seltzer Plus Cold

Name: Alka-Seltzer Plus Cold

Dosing & Uses

Dosage Forms & Strengths

aspirin/chlorpheniramine/phenylephrine

effervescent tablet

  • 325mg/2mg/7.8mg

Temporary Relief of Common Cold Cough & Upper Respiratory Symptoms

2 tablets fully dissolved in 4 oz of water q4hr; not to exceed 8 tablets/day

Dosage Forms & Strengths

aspirin/chlorpheniramine/phenylephrine

effervescent tablet

  • 325mg/2mg/7.8mg

Temporary Relief of Common Cold Cough & Upper Respiratory Symptoms

Alka-Seltzer Plus Cold

  • 12 years: 2 tablets fully dissolved in 4 oz of water q4hr; not to exceed 8 tablets/day

Adverse Effects

Frequency Not Defined

Dysrhythmias

Hypotension

Tachycardia

Agitation

Cerebral edema

Coma

Confusion

Dizziness

Headache

Subdural or intracranial hemorrhage

Lethargy

Hives

Rashes

May potentiate peptic ulcer and cause stomach distress or heartburn

Dyspepsia

GI bleeding

Ulceration and perforation

Nausea

Vomiting

Prolonged prothrombin time

Palpitations

Sedation

Fatigue

Confusion

Depression

Tremors

Irritability

Insomnia

Euphoria

Hemolytic anemia

Thrombocytopenia

Agranulocytosis

Anorexia

Wheezing

Thickening of bronchial secretions

Restlessness

Headache

Hypertension

Severe peripheral and visceral vasoconstriction

Warnings

Contraindications

Hypersensitivity

Liver damage

Hypoprothrombinemia

Vitamin K deficiency

Bleeding disorders

Asthma

Due to association of aspirin with Reye syndrome, do not use in children (

Pregnancy & Lactation

Pregnancy category D; avoid during pregnancy, especially during third trimester (risk for premature closure of ductus arteriosus)

Lactation: Excreted in breast milk; do not breast feed

Pregnant or breastfeeding patients should seek advice of health professional before using OTC drugs

Pregnancy Categories

A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA: Information not available.

Patient Handout

Print without Office InfoPrint with Office Info
(web3)